Latest Content

Catch up on the top stories in optometry during the week of August 3-7.

Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

Harrow to acquire Tyrvaya, the only FDA-approved nasal spray for dry eye disease, from Viatris for up to $100 million, complementing its cyclosporine product Vevye.

Findings highlight the need for routine bilateral endothelial assessment in herpetic eye disease.

Myopia-control spectacle lenses reduce short-term progression in children by about 50%, though efficacy and long-term durability vary.

Leslie Scher, OD, discussed the importance of scheduling pediatric comprehensive eye exams. She also shared how her practice manages the influx of patients during the busy back to school season.

Segmented refractive index modeling reduced axial length errors linked to crystalline lens variation, but clinical validation is needed.

Physicians recommend a Mediterranean or similar diet to slow the progression of age-related macular degeneration, the leading cause of irreversible vision loss in older adults.

Pamela Theriot, OD, FAAO, discussed comprehensive eye exams, managing pediatric dry eye symptoms, and avoiding digital eye strain as back to school season begins.

Weighing in on The Lancet Diabetes & Endocrinology's expert panel and its division of obesity diagnoses.

Catch up on the top stories in optometry during the week of July 27-31.

PROSE treatment and Mackie stage improvement in neurotrophic keratitis: retrospective study design and primary results.

Maria Sampalis, OD, weighs in on how she has tripled her private practice's growth during her career and how she has used the back to school season as an opportunity to strengthen that growth.